With the signing of this contract, both companies benefit from synergies in distribution and market access. SANOCHEMIA is now also able to provide high quality next generation contrast injectors as well as consumables along with its pharmaceutical products. SANOCHEMIA expects a maximum sales growth with the launch of this new product line.
“With access to VIVID IMAGING’s next generation injector series, SANOCHEMIA is able to strengthen its competences in the medical field. This partnership enables us to offer our international customers a wide range of daily use products in the field of imaging diagnostic.” Dr. Klaus Gerdes, CMO, COO.
Mark Chelberg, President of VIVID IMAGING also welcomes the cooperation with SANOCHEMIA: “We look forward to our partnership with SANOCHEMIA. Our value range contrast injectors and accessory syringe line complement SANOCHEMIA’s core product line, enabling SANOCHEMIA to offer its client’s a turnkey contrast and delivery solution.”